StonvexLoading…
StonvexStonvexStonvexCore line items from INGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.79B | $7.22B | $1.82B | $1.83B |
Operating Income | $203.00M | $1.02B | $796.00M | $547.00M |
Net Income | $142.00M | $729.00M | $171.00M | $196.00M |
EPS (Diluted) | $2.22 | $11.18 | $2.61 | $2.99 |
Total Assets | $7.93B | $7.90B | $7.83B | $7.78B |
Total Liabilities | $3.48B | $3.53B | $3.51B | $3.50B |
Cash & Equivalents | $914.00M | $1.03B | $915.00M | $861.00M |
Free Cash Flow OCF − CapEx | $-77.00M | $511.00M | $241.00M | $69.00M |
Shares Outstanding | 64.00M | 65.20M | 65.50M | 65.60M |